Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: BioVie Inc., 1 year.
BioVie Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Akari Therapeutics plc | Grant or award | +1,728 | $7.52 | $12,995 |
| Jul 16, 2026 | Akari Therapeutics plc | Grant or award | +1,130 | $11.50 | $12,995 |
| Jun 24, 2026 | Akari Therapeutics plc | Grant or award | +1,248 | $10.02 | $12,505 |
| Jun 24, 2026 | Akari Therapeutics plc | Grant or award | +1,395 | $9.32 | $13,001 |
| Jun 24, 2026 | Akari Therapeutics plc | Grant or award | +1,570 | $8.28 | $13,000 |
| Jun 24, 2026 | Akari Therapeutics plc | Grant or award | +2,539 | $5.12 | $13,000 |
| Jun 24, 2026 | Akari Therapeutics plc | Grant or award | +3,725 | $3.49 | $13,000 |
| Jun 24, 2026 | Akari Therapeutics plc | Grant or award | +7,353 | $3.74 | $27,500 |
| Jun 24, 2026 | Akari Therapeutics plc | Grant or award | +1,000 | $13.00 | $13,000 |
| Nov 1, 2025 | Akari Therapeutics plc | Grant or award | +32,000 | $0.75 | $24,000 |
| Nov 1, 2025 | Akari Therapeutics plc | Grant or award | +26,619 | $0.75 | $19,964 |
| Oct 22, 2025 | Akari Therapeutics plc | Grant or award | +6,277 | $0.74 | $4,645 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.